Cite
HARVARD Citation
Liu, W. et al. (2022). Rapamycin ameliorates chronic intermittent hypoxia and sleep deprivation-induced renal damage via the mammalian target of rapamycin (mTOR)/NOD-like receptor protein 3 (NLRP3) signaling pathway. Bioengineered. 13 (3), pp. 5537-5550. [Online].